文献速递头颈神经MRPET

扩散加权成像与18F-FDG-PET/CT对以颈部转移为首发表现的头颈部原发灶不明癌的诊断价值

Diagnostic value of diffusion-weighted imaging and 18F-FDG-PET/CT for the detection of unknown primary head and neck cancer in patients presenting with cervical metastasis.
PubMed 文献 · Eur J Radiol · 2018-08-11

该回顾性研究纳入31例病理证实的头颈部鳞状细胞癌颈部淋巴结转移、原发灶不明的患者,评估DWI与18F-FDG-PET/CT检测原发灶的诊断价值。定性分析MRI(含DWI)敏感度81.3%、特异度73.3%;定性分析18F-FDG-PET/CT敏感度93.8%、特异度73.3%;SUVmax定量分析敏感度81.3%、特异度93.3%;联合DWI与PET/CT敏感度93.8%、特异度60.0%。结论为DWI与18F-FDG-PET/CT定性分析及PET/CT的SUVmax定量分析诊断准确度高,加做DWI未提高PET/CT的准确度。

要点

  • 定性分析18F-FDG-PET/CT检测原发灶敏感度93.8%(95%CI 67.8-99.7)、特异度73.3%(95%CI 44.8-91.1)。
  • SUVmax定量分析敏感度81.3%(95%CI 53.6-95.0)、特异度93.3%(95%CI 66.0-99.7)。
  • 联合DWI与18F-FDG-PET/CT敏感度93.8%(95%CI 67.7-99.7)、特异度60.0%(95%CI 32.9-82.5),加做DWI未提高PET/CT准确度。

核心结论

  • 在本组临床原发灶不明的头颈部鳞状细胞癌患者中,DWI与18F-FDG-PET/CT定性分析及PET/CT的SUVmax定量分析诊断准确度高,加做DWI未提高18F-FDG-PET/CT的准确度。

研究设计与样本

  • 回顾性研究,纳入2013年1月至2016年11月间31例(男/女=23/8,中位年龄66岁,年龄范围40-80岁)病理证实的头颈部鳞状细胞癌颈部淋巴结转移且无明确原发灶的患者。
  • 所有患者均接受DWI和18F-FDG-PET/CT检查,两种方法均行定性及定量评估,采用ROC分析确定区分隐匿性恶性肿瘤与良性组织的最佳截断值。

诊断标准与关键数值

  • MRI(含DWI)定性分析:敏感度81.3%(95%CI 53.7-95.0),特异度73.3%(95%CI 44.8-91.1)。
  • 18F-FDG-PET/CT定性评分:敏感度93.8%(95%CI 67.8-99.7),特异度73.3%(95%CI 44.8-91.1)。
  • SUVmax定量分析:敏感度81.3%(95%CI 53.6-95.0),特异度93.3%(95%CI 66.0-99.7)。
  • DWI联合18F-FDG-PET/CT:敏感度93.8%(95%CI 67.7-99.7),特异度60.0%(95%CI 32.9-82.5)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Head and neck squamous cell carcinoma (HNSCC) may present with cervical metastases without an apparent primary tumor. Detecting the primary tumor results in more targeted treatment. Acquisition of DWI is improving with less artifacts and image distortion. We assessed the diagnostic value of DWI and 18F-FDG-PET/CT for detecting primary tumors in patients presenting with nodal metastasis of an unknown primary HNSCC.

MATERIALS AND METHODS: For this retrospective study we included 31 patients (male/female ratio = 23/8, median age = 66 years, age range = 40-80 years) who presented with a pathologically proven cervical nodal metastasis from HNSCC without overt primary tumor location between January 2013 and November 2016 and underwent both DWI and 18F-FDG-PET/CT. Both modalities were assessed qualitatively and quantitatively. With ROC analysis we determined the optimal cut-off for imaging parameters in separating occult malignancy from benign tissue.

RESULTS: Qualitative analysis of MRI including DWI resulted in a sensitivity of 81.3% (95%CI) = 53.7-95.0) and specificity of 73.3% (95%CI = 44.8-91.1). With qualitative scoring of 18F-FDG-PET/CT a sensitivity and specificity of 93.8% (95%CI = 67.8-99.7) and 73.3% (95%CI = 44.8-91.1) were found. With quantitative analysis sensitivity and specificity of SUVmax were 81.3% (95%CI = 53.6-95.0) and 93.3% (95%CI = 66.0-99.7), respectively. Combining DWI and 18F-FDG-PET/CT resulted in a sensitivity of 93.8% (95%CI = 67.7-99.7%) and specificity of 60.0% (95%CI = 32.9-82.5%).

CONCLUSION: In this study on HNSCC patients presenting with clinically UP lesions the diagnostic accuracy of qualitative analysis with DWI and 18F-FDG-PET/CT and quantitative analysis of 18F-FDG-PET/CT using SUVmax were high. Adding DWI did not improve the accuracy of 18F-FDG-PET/CT.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Noij DP, Martens RM, Zwezerijnen B, et al. Diagnostic value of diffusion-weighted imaging and 18F-FDG-PET/CT for the detection of unknown primary head and neck cancer in patients presenting with cervical metastasis. Eur J Radiol. 2018. PMID: 30292267. doi:10.1016/j.ejrad.2018.08.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。